Orthofix Medical Inc. OFIX Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Before Tax

Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Before Tax at other companies

American Coastal Insurance CorporationACIC

$6K-99.6%

Greene County BancorpGCBC

$0+100%

CitizensCIA

-$412K-396%

Peoples Financial ServicesPFIS

$510K+191%

BankUnitedBKU

$3.4M+312%

NFB

Northfield BancorpNFBK

-$2K—

Other financials

Income statement

See full

Revenue$196.7M+1.6%

Gross profit$139.5M+14.7%

Operating income-$14.4M+70.5%

Net income-$20.9M+60.6%

EPS (diluted)-$0.52+61.5%

Balance sheet

See full

Cash & equivalents$120.3M+108%

Total debt$237.5M+32.3%

Total equity$435.2M-5.0%

Total assets$886.6M+7.7%

Cash flow

See full

Operating cash flow-$17.6M+4.2%

CapEx$10.7M+58.3%

Free cash flow-$28.3M-12.5%

Valuation

See full

Market cap$376.33M-7.1%

Enterprise value$493.54M-6.3%

P/S0.5×0.0×

Profitability

See full

Gross margin70.7%+3.6pp

Operating margin-5.8%-2.1pp

Net margin-7.3%-2.7pp

FCF margin-9.3%-1.7pp

Returns & leverage

See full

Return on equity-13.4%-4.6pp

Debt / equity0.5×+0.2×

Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax.

The official record: Orthofix Medical Inc.’s 10-Q, filed August 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s other comprehensive income loss reclassification adjustment from aoci for sale of securities before tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Orthofix Medical Inc.'s other comprehensive income loss reclassification adjustment from AOCI for sale of securities before tax?: Orthofix Medical Inc. (OFIX) reported other comprehensive income loss reclassification adjustment from AOCI for sale of securities before tax of $1.67M in Q2 2024.